Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, today announced ...
Diverse representation and maintained participant engagement are critical goals of clinical research. While community ...
Clark, Executive Director, Patient Innovation & Engagement, Global Medical and Scientific Affairs at Merck, about the ...
Phase 2 trial is an adaptive designed randomized study comparing NGC-Cap to monotherapy capecitabineResults from this Phase 2 trial will evaluate ...
We’re only a few months a way from the end of the year, but pharma companies still have a steady stream of clinical trial ...
In September, the Securities and Exchange Commission brought charges against Cassava Sciences, alleging that the company had ...
Monogram has obtained FDA clearance for mPress implants and applied for 510 (k) clearance for its robotic products. The Company is required to obtain FDA clearance before it can market its products.
A small clinical trial has found that at low doses, lithium aspartate is ineffective in treating the fatigue and brain fog that is often a persistent feature of long COVID.
The only available treatment for HDFN can itself be fatal, but a clinical trial led by an Austin researcher offers new hope ...
This partnership is poised to revolutionize clinical insights and decision-making for the pharma industry with the aim of ...
Car-T cell therapy has changed the face of many cancer treatments, but the level of customization it requires still comes ...
On September 20, the FDA approved isatuximab plus bortezomib, lenalidomide, and dexamethasone in the first line for patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback